Quantification of Active and Total Adalimumab using Affinity Purification Coupled with Tryptic Digestion-Based Liquid Chromatography-Tandem Mass Spectrometry …
1. 请及时下载文件确认是否正确, 系统将在 2025-10-20 14:51:34 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://www.sciencedirect.com/science/article/abs/pii/S0731708525005230?dgcid=raven_sd_aip_email
其他信息:
X Hou, Y Liu, Z Cai, Y Chen, S Li, L Su, F Fang…
… of Pharmaceutical and …, 2025
Elsevier
Therapeutic drug monitoring is commonly employed to investigate the loss of response to adalimumab. However, existing methodologies focus exclusively on measuring active adalimumab, neglecting the presence of inactive forms, which may result in incomplete or misleading clinical evaluations. To address this limitation, a liquid chromatography-tandem mass spectrometry method incorporating affinity purification was developed for the simultaneous quantification of both active and total adalimumab concentrations in serum …
